HEPA

Hepion Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Hepion Pharmaceuticals Inc HEPA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0224 3.91% 0.5949 14:55:09
Open Price Low Price High Price Close Price Prev Close
0.57 0.57 0.605 0.5725
more quote information »

Recent News

Date Time Source Heading
6/30/202206:01EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
6/28/202209:47EDGARCurrent Report Filing (8-k)
6/28/202208:30GLOBEHepion Pharmaceuticals Further Strengthens Board with..
6/27/202206:06EDGARCurrent Report Filing (8-k)
6/24/202216:25EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
6/24/202216:15GLOBEHepion Pharmaceuticals Announces Adjournment of Annual..
6/20/202208:00GLOBEHepion Pharmaceuticals Receives FDA Orphan Drug Status..
6/15/202208:00GLOBEHepion Pharmaceuticals to Present Five Posters at EASL..
6/14/202208:00GLOBEHepion Pharmaceuticals Appoints Accomplished Life Sciences..
6/06/202216:17EDGARCurrent Report Filing (8-k)
5/31/202216:53EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/31/202216:30GLOBEHepion Pharmaceuticals Urges Shareholders to Vote “FOR” All..
5/27/202208:53GLOBECORRECTING and REPLACING - Hepion Pharmaceuticals, Inc.
5/27/202208:45EDGARCurrent Report Filing (8-k)
5/27/202208:00GLOBEHepion Pharmaceuticals Highlights Upcoming Phase 2 Clinical..
5/16/202216:46EDGARQuarterly Report (10-q)
5/03/202208:00GLOBEHepion Pharmaceuticals Announces Clinical Collaboration with..
4/29/202217:29EDGARProxy Statement (definitive) (def 14a)
4/20/202217:30EDGARProxy Statement - Notice of Shareholders Meeting..
4/08/202217:27EDGARAnnual Report (10-k)
3/07/202208:00GLOBEHepion Pharmaceuticals to Present at the Q1 Investor Summit..
2/15/202208:00GLOBEHepion Pharmaceuticals Appoints World-Renowned Hepatologist,..
2/14/202208:00GLOBEHepion Pharmaceuticals to Present at BIO CEO & Investor..
2/14/202206:16EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202208:38EDGARAmended Statement of Ownership (sc 13g/a)
1/26/202209:34SEEKHepion's rencofilstat combo reduces tumor growth in..
1/26/202208:00GLOBEHepion Pharmaceuticals’ Rencofilstat, in Combination with an..
1/19/202210:49EDGARAmended Statement of Ownership (sc 13g/a)
1/12/202210:09EDGARCurrent Report Filing (8-k)
1/12/202208:00GLOBEHepion Pharmaceuticals Announces Death of Director, Thomas..
1/10/202206:05EDGARCurrent Report Filing (8-k)
1/06/202216:15GLOBEHepion Pharmaceuticals Announces USAN Selection of..
1/05/202216:30GLOBEHepion Pharmaceuticals Announces Participation in the H.C...
1/05/202208:30GLOBEHepion Pharmaceuticals to Present Clinical Data at NASH-TAG..
1/04/202206:01EDGARAmended Statement of Ownership (sc 13g/a)
12/21/202108:51SEEKFDA clears Hepion Pharma's CRV431 application for liver..
12/21/202108:25EDGARCurrent Report Filing (8-k)
12/21/202108:00GLOBEHepion Pharmaceuticals Announces FDA Clearance of IND..
11/30/202108:56SEEKHepion Pharmaceuticals gets FDA fast track designation for..
11/30/202108:10EDGARCurrent Report Filing (8-k)
11/30/202108:00GLOBEHepion Pharmaceuticals Receives FDA Fast Track Designation..
11/26/202106:09EDGARNotice of Effectiveness (effect)
11/19/202117:01EDGARSecurities Registration Statement (simplified Form) (s-3/a)
11/16/202109:11SEEKHepion Pharma reports anti-cancer activity of CRV431 in a..
11/16/202108:54EDGARCurrent Report Filing (8-k)
11/16/202108:45GLOBEHepion Pharmaceuticals and FibroFind Announce Anti-Cancer..
11/15/202116:50EDGARQuarterly Report (10-q)
11/10/202108:00GLOBEHepion Pharmaceuticals Announces Poster Details for the..
11/10/202107:55GLOBEAnti-Cancer Mechanism of Hepion Pharmaceuticals’ CRV431..
11/04/202108:00GLOBEHepion Pharmaceuticals Presents at the EquitiesIQ Q4 2021..


Your Recent History
NASDAQ
HEPA
Hepion Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.